Comparison of Efficacy of Suprachoroidal Triamcinolone Acetonide Alone or in Combination With Intravitreal Bevacizumab for Treatment of Diabetic Macular Edema: A Prospective Comparative Study. (PubMed, Health Sci Rep) - Oct 2, 2026 - "Suprachoroidal administration of 4 mg triamcinolone acetonide combined with intravitreal bevacizumab is more effective than triamcinolone monotherapy in reducing central subfield thickness and improving visual acuity in patients with DME. The combination approach provides superior anatomical and functional outcomes, suggesting a synergistic therapeutic effect and representing a promising treatment strategy for DME."
Journal • Diabetic Macular Edema • Ophthalmology
|
|
Aalaa Saleh; Asad Aslam Khan; Chaudhry Nasir Ahmed; Faisal Anwar; Mohammad Hasan Bokhari; Muhammad Tahir Ghaffar; Tahseen Mahmood Majhu
|